Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma

BACKGROUND: Advances in genomics have greatly improved the survival rate in cancer patients. However, due to genetic heterogeneity, pancreatic ductal adenocarcinoma (PDAC) is still difficult to diagnose early, and its survival rate is extremely low. Therefore, we identified biomarkers that predict t...

Descripción completa

Detalles Bibliográficos
Autores principales: Goh, Tae Sik, Ha, Mihyang, Lee, Jung Sub, Jeong, Dae Cheon, Jung, Eun Sang, Han, Myoung-Eun, Kim, Yun Hak, Oh, Sae-Ock
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472433/
https://www.ncbi.nlm.nih.gov/pubmed/31043796
http://dx.doi.org/10.2147/OTT.S202101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472433/
https://www.ncbi.nlm.nih.gov/pubmed/31043796
http://dx.doi.org/10.2147/OTT.S202101

Ejemplares similares